Key result
Extending the duration of oral anticoagulation beyond 4-6 weeks for venous thromboembolism requires weighing individual factors such as hemorrhage risk, recurrence, compliance, and cost.
Why the study?
What is the optimal duration of oral anticoagulant therapy in patients with venous thromboembolism?
Population
Patients with venous thromboembolism
Comparison
Extended duration of oral anticoagulant therapy vs Standard duration (4-6 weeks)
Design
Review
Authors
Loading...
Supports individualized VTE anticoagulation decisions balancing patient factors; leaves open refined risk stratification via prospective trials.
What is the optimal duration of oral anticoagulant therapy in patients with venous thromboembolism?
The optimal duration of oral anticoagulation for VTE often extends beyond 4-6 weeks and requires individualized decision-making balancing recurrence and bleeding risks.
Sam Schulman (1997) conducted a review in Venous Thromboembolism. Oral Anticoagulant Therapy was evaluated. Extending the duration of oral anticoagulation beyond 4-6 weeks for venous thromboembolism requires weighing individual factors such as hemorrhage risk, recurrence, compliance, and cost.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: